Pliant Therapeutics Inc (FRA:9PT)
€ 10.9 -0.3 (-2.68%) Market Cap: 616.74 Mil Enterprise Value: 279.48 Mil PE Ratio: 0 PB Ratio: 1.87 GF Score: 38/100

Pliant Therapeutics Inc INTEGRIS-PSC Interim Phase 2a Data Presentation Transcript

Sep 26, 2023 / 12:00PM GMT
Release Date Price: €14.9 (+6.43%)

Sep 26, 2023 / 12:00PM GMT
Presentation
Sep 26, 2023 / 12:00PM GMT

=====================
Corporate Participants
=====================
* Chris Keenan
Pliant Therapeutics, Inc. - Vice President, Investor Relations and CorporateCommunications
* Bernard Coulie
Pliant Therapeutics, Inc. - President & CEO
* Ãric Lefebvre
Pliant Therapeutics, Inc. - Chief Medical Officer
* Gideon Hirschfield
University of Toronto - Lily and Terry Horner Chair in Autoimmune Liver DiseaseResearch & Investigator

=====================
Conference Call Participants
=====================
* Brian Abrahams
RBC Capital Markets - Analyst
* Yasmeen Rahimi
Piper Sandler - Analyst
* Ritu Baral
TD Cowen - Analyst
* Jeff Jones
Oppenheimer - Analyst
* Eric Joseph
JP Morgan - Analyst
* Mike Kratky
Leerink Partners - Analyst
* David Lebowitz
Citi - Analyst
* Tom Shrader
BTIG - Analyst
* Joel Beatty
Robert W Baird & Co Inc - Senior

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot